Viking Therapeutics, Inc.
VKTX
$24.99
-$0.67-2.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 851.86M | 902.61M | 930.44M | 942.26M | 962.98M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 865.00K | 1.13M | 1.73M | 138.00K | 643.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.30M | 3.48M | 4.48M | 3.32M | 2.72M |
| Total Current Assets | 866.02M | 907.22M | 936.65M | 945.72M | 966.34M |
|
|
|||||
| Total Current Assets | 866.02M | 907.22M | 936.65M | 945.72M | 966.34M |
| Net Property, Plant & Equipment | 892.00K | 1.00M | 1.11M | 977.00K | 1.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 78.00K | 102.00K | 126.00K | 138.00K | 131.00K |
| Total Assets | 866.99M | 908.32M | 937.89M | 946.84M | 967.52M |
|
|
|||||
| Total Accounts Payable | 7.70M | 9.81M | 254.00K | 11.09M | 5.23M |
| Total Accrued Expenses | 11.37M | 17.11M | 24.95M | 13.67M | 27.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 498.00K | 489.00K | 480.00K | 334.00K | 329.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.57M | 27.41M | 25.69M | 25.09M | 32.77M |
|
|
|||||
| Total Current Liabilities | 19.57M | 27.41M | 25.69M | 25.09M | 32.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 502.00K | 630.00K | 755.00K | 766.00K | 852.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.08M | 28.04M | 26.44M | 25.86M | 33.63M |
|
|
|||||
| Common Stock & APIC | 1.38B | 1.37B | 1.36B | 1.35B | 1.34B |
| Retained Earnings | -533.54M | -487.91M | -452.49M | -427.55M | -405.30M |
| Treasury Stock & Other | -216.00K | -788.00K | 1.63M | -2.27M | -1.60M |
| Total Common Equity | 846.92M | 880.28M | 911.45M | 920.98M | 933.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 846.92M | 880.28M | 911.45M | 920.98M | 933.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 846.92M | 880.28M | 911.45M | 920.98M | 933.89M |
|
|
|||||